Mercury Data Science announces the publication of collaborative work with the Janssen Neuroscience team at the 61st American College of Neuropsychopharmacology (ACNP) Annual Meeting.
This work furthers efforts to identify clinical subtypes and perform digital biomarker-based stratification in autism based on EEG, ECG, and other biosensors. These insights will be used to inform future clinical trial study designs. Mercury Data Science is proud of this collaboration and shares special acknowledgment to Savannah Gosnell, PhD and Wen-Hsuan Chan, PhD for their expertise and involvement in this work.
P395. Replication of the N170 Response to Faces for Use as a Potential Stratification Biomarker in Clinical Trials for Autism Spectrum Disorder
P396. Identification of Stable Clinical Subtypes in Autism Spectrum Disorder Using the Autism Behavior Inventory
A data science platform to support biomarker discovery
Data science strategy for biomarker discovery
P396 & P395
A scalable data science platform to orchestrate clinical trial analysis workflows and analyze results
A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!
Below is an image